ZYBERNO
Stock Report
Updated Aug 23, 2026

BESPOKE EXTRACTS, INC. (BSPK)

Healthcare • OTC

$0.00

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
14.0/100
POOR BUSINESS
BESPOKE EXTRACTS, INC. (BSPK) scores 14/100 — concerning metrics indicating significant structural or financial risks.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (0.0%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.00x)
Operating Margin (Operational Efficiency):CRITICAL (-45.0%)
Return on Capital (Capital Efficiency):CRITICAL (-170.8%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

BESPOKE EXTRACTS, INC. (BSPK) stock report — Zyberno Score 14/100 (POOR BUSINESS). Full financial analysis on Zyberno.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.00
Market Cap:$10.12K

Valuation Multiples (2)

P/S Ratio:0.01x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$1.44M
B. Profitability Assessment

Margin Analysis (3)

Operating Margin Ttm:-45.0%
Net Margin Ttm:-51.3%
Ebitda Margin:-44.4%

TTM Performance (3)

Gross Margin Ttm:47.2%
Operating Margin Ttm:-45.0%
Net Margin Ttm:-51.3%

Yield Metrics (2)

Earnings Yield:-$8.57K
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:-400.0%
Latest Earnings Filed:2025-11-12

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):55.1%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:0.11x
Quick Ratio:0.07x
Cash Ratio:0.01x

Leverage Analysis (1)

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-21.36x
Times Interest Earned:-21.36

Capital Structure (4)

Working Capital:-1,675,749.00
Cash And Cash Equivalents:14,416.00
Long Term Debt:$52.65K
Net Debt:$1.43M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $1.42M
Linear Growth: 55.1%
📊 Click to view full BSPK Revenue analysis & methodology →
Cost Of Revenue Ttm:$751.35K

Profitability Breakdown (2)

Gross profit TTM: $671.70K
Linear Growth: 100.0%
📊 Click to view full BSPK Gross Profit analysis & methodology →
-$640.30K

Bottom Line Performance (3)

-$730.56K
Income Before Tax:-$730.56K
Ebitda Ttm:-632,329.00

Operating Expenses (5)

Operating Expenses:1,311,996.00
R And D Expense:0.00
Sga Expense:1,225,900.00
Income Tax Expense:$0.00
Interest Expense:46,556.00

Expense Ratios (3)

R And D To Revenue Percentage:0.0%
Sga To Revenue Percentage:262.0%
Ebitda Margin:-44.4%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$295.57K
Current Assets:$196.83K
Ppe Net:24,051.00
Goodwill:0.00
Intangible Assets:$0.00

Liability Structure (4)

Total Liabilities:2,891,081.00
Current Liabilities:1,872,581.00
Long Term Debt:$52.65K
Short Term Debt:$1.39M

Equity & Capital (3)

Equity:-$2.60M
Retained Earnings:-$26.95M
Common Stock:3,000,000,000.00

Working Capital Items (3)

Accounts Receivable:103,532.00
Inventory:63,662.00
Accounts Payable:1,392,869.00

Special Items (2)

Contract Liabilities:0.00
Stock Based Compensation:2,960.00
C. Cash Flow Analysis

Operating Activities (2)

-$265.55K-$889.80K

Investment Activities (1)

Investing Cash Flow:$0.00

Financing Activities (3)

Financing Cash Flow:$43.00K
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:7,972.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.06
-$0.06
Earnings Per Share Ttm:-$0.06

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.13
Operating Cash Flow Per Share:-$0.03

Book Value & Capital (2)

Book Value Per Share:-$0.23
Cash Per Share:0.00

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:4.87x
Working Capital Turnover Ttm:-999.00x

Receivables Management (2)

Receivables Turnover Ttm:13.74x
Days Sales Outstanding Ttm:26.56

Inventory Management (2)

Inventory Turnover Ttm:11.80x
Days Inventory Outstanding Ttm:30.93

Payables & Cash Cycle (2)

Days Payable Outstanding:676.64
Cash Conversion Cycle:-619.16
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:20.00
Quality Score:20.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):55.1%

Other Growth Rates (1)

Gross Profit Growth Rate (Linear):100.0%
C. Company Profile & Context

Corporate Information (6)

Symbol:BSPK
Company Name:BESPOKE EXTRACTS, INC.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:11.25M
Shares Outstanding Basic:11.25M
Shares Outstanding Diluted:11.25M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-23 12:48:37 UTC
Data Timestamp:2026-08-22T14:23:56.471424
Scroll to Top